Neurologic Outcomes in Patients with MS and Neuromyelitis Optica Spectrum Disorder Exposed to Immune Checkpoint Inhibitors

The chapter delves into a study on patients with multiple sclerosis and neuromyelitis optica spectrum disorder exposed to immune checkpoint inhibitors, revealing varied outcomes between the two cohorts. It highlights the rarity of ICI-associated disease activity in older MS patients and the potential for severe myelitis in neuromyelitis optica spectrum disorder patients despite prior stability.